Current trends in pityriasis rosea

References

• Drago F, Broccolo F, Rebora A. Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology. J. Am. Acad. Dermatol.61, 303–318 (2009).
   PubMed Web of Science ®Google Scholar
• Holubar K. Robert Willan’s description and treatment of cutaneous diseases 1797/1798: a bicentennial. J. Invest. Dermatol.110, 101 (1998).
   PubMedGoogle Scholar
• Gonzalez L, Allen R, Janniger C, Schwartz R. Pityriasis rosea: an important papulo-squamous disorder. Int. J. Dermatol.44, 757–764 (2005).
   PubMed Web of Science ®Google Scholar
• Chuh A, Lee A, Zawar V, Sciallis G, Kempf W. Pityriasis rosea – an update. Indian J. Dermatol. Venereol. Leprol.71, 311–315 (2005).
   PubMedGoogle Scholar
• Bjornberg A, Hallgren L. Pityriasis rosea, a statistical, clinical and laboratory investigation of 826 patients and matched healthy controls. Acta Derm. Venereol.Suppl. (Stockh.) 42, 1–68 (1962).
   PubMedGoogle Scholar
• Sharma L, Shrivastava K. Clinico-epidemiological study of pityriasis rosea. Ind. J. Dermatol. Venereol. Leprol.74, 647–649 (2008).
   PubMed Web of Science ®Google Scholar
• Chuh A, Molinari N, Sciallis G, Harman M, Akdeniz S, Nanda A. Temporal case clustering in pityriasis rosea. Regression analysis of 1379 cases in Minnesota, Kuwait and Diyrbrkir, Turkey. Arch. Dermatol.141, 767–771 (2005).
   PubMedGoogle Scholar
• Bozdag KE, Güven FO, Zeytinoglu A, Erensoy S, Karaman A, Bilgiç A. Investigation of herpes simplex virus DNA in pityriasis rosea by polymerase chain reaction. Int. J. Dermatol.44, 477–478 (2005).
   PubMedGoogle Scholar
• Stinco G, Ruscio M, Proscia D, Piccirillo F. Borrelia infection and pityriasis rosea. Acta. Derm. Venereol.89, 97–98 (2009).
   PubMedGoogle Scholar
• Chia JK, Shitabata P, Wu J, Chia AY. Enterovirus infection as a possible cause of pityriasis rosea: demonstration by immunochemical staining. Arch. Dermatol.142, 942–943 (2006).
   PubMedGoogle Scholar
• Chuh A, Zawar V, Lee A. Atypical presentations of pityriasis rosea: case presentations. J. Eur. Acad. Dermatol. Venereol.19, 120–126 (2005).
   PubMed Web of Science ®Google Scholar
• Robati RM, Toossi P. Plantar herald patch in pityriasis rosea. Clin. Exp. Dermatol.34, 269–270 (2009).
   PubMedGoogle Scholar
• Pringle JJ. Case presentations, section on dermatology, Royal Society of Medicine. Br. J. Dermatol.27, 309 (1915).
   Google Scholar
• Klauder JV. Pityriasis rosea with particular reference to its unusual manifestation. JAMA82, 178–183 (1924).
   Google Scholar
• Zawar V. Giant pityriasis rosea. Indian J. Dermatol.55, 192–194 (2010).
   PubMedGoogle Scholar
• Ang CC, Tay YK. Blachkoid pityriasis rosea. J. Am. Acad. Dermatol.61, 906–908 (2009).
   PubMedGoogle Scholar
• Deng Y, Li H, Chen X. Palmoplantar pityriasis rosea: two case reports. J. Eur. Acad. Dermatol. Venereol.21, 406–407 (2007).
   PubMedGoogle Scholar
• Gibney MD, Leonardi CL. Acute papulo-squamous eruptions of the extremities demonstrating isomorphic response. Inverse pityriasis rosea. Arch. Dermatol.133, 654 (1997).
   Google Scholar
• Ahmed I, Charles-Holmes R. Localized pityriasis rosea. Clin. Exptl. Dermatol.25, 624–626 (2000).
   PubMedGoogle Scholar
• Brar BK, Pall A, Gupta RR. Pityriasis rosea unilateralis. Indian J. Dermatol. Venereol. Leprol.69(1), 42–43 (2003).
   PubMedGoogle Scholar
• Sciubba JJ. Oral lesions associated with pityriasis rosea. Arch. Dermatol.122, 503–504 (1986).
   PubMedGoogle Scholar
• Kay MH, Rapini RP, Fritz KA. Oral lesions in pityriasis rosea. Arch. Dermatol.121, 1449–1451 (1985).
   PubMedGoogle Scholar
• Bernardin RM, Ritter SE, Murchland MR. Papular pityriasis rosea. Cutis70, 51–55 (2002).
   PubMedGoogle Scholar
• Griffiths A. Vesicular pityriasis rosea. Arch. Dermatol.113, 1733–1734 (1977).
   PubMedGoogle Scholar
• Balci DD, Hakverdi S. Vesicular pityriasis rosea: an atypical presentation. Dermatol. Online J.14(3), 6 (2008).
   PubMedGoogle Scholar
• Pierson JC, Dijkstra JW, Elston DM. Purpuric pityriasis rosea. J. Am. Acad. Dermatol.28, 1021 (1993).
   PubMedGoogle Scholar
• Paller AS, Esterly NB, Lucky AW, Milstone EB, Higgins TP. Hemorrhagic pityriasis rosea: an unusual variant. Pediatrics70, 357–359 (1982).
   PubMedGoogle Scholar
• Friedman SJ. Pityriasis rosea with erythema multiforme-like lesions. J. Am. Acad. Dermatol.17, 135–136 (1987).
   PubMed Web of Science ®Google Scholar
• Chuh AAT. Diagnostic criteria for pityriasis rosea: a prospective case control study for assessment of validity. J. Eur. Acad. Dermatol.17, 101–103 (2003).
   Google Scholar
• Browning JC. An update on pityriasis rosea and other similar childhood exanthems. Curr. Opin. Pediatr.21, 481–485 (2009).
   PubMed Web of Science ®Google Scholar
• Horn T, Kazakis A. Pityriasis rosea and need for serologic test for syphilis. Cutis39, 81–82 (1987).
   PubMedGoogle Scholar
• Bunch LW, Tilley JC. Pityriasis rosea: a histologic and serologic study. Arch. Dermatol.84, 79–86 (1961).
   PubMedGoogle Scholar
• Pannizon R, Block PH. Histopathology of pityriasis rosea Gilbert. Dermatologica165, 551–558 (1982).
   PubMedGoogle Scholar
• Okamoto H, Imamura S, Aoshima T. Dyskeratotic degeneration of epidermal cells in pityriasis rosea: light and electron microscopic studies. Br. J. Dermatol.107, 189–194 (1982).
   PubMedGoogle Scholar
• Taeami H, Uehara M. Multinucleated giant cells in inflammatory skin diseases. Arch. Dermatol.117, 23–25 (1981).
   PubMedGoogle Scholar
• Prasad D, Mittal RR, Walia R, Popli R. Pityriasis rosea: a histopathologic study. Indian J. Dermatol. Venereol. Leprol.66, 244–246 (2000).
   PubMedGoogle Scholar
• Vollum DI. Pityriasis rosea in Africans. Trans. St Johns Hosp. Dermatol. Soc.59, 269–271 (1973).
   PubMedGoogle Scholar
• Jacyk WK. Pityriasis rosea in Nigerians. Int. J. Dermatol.19, 397–399 (1980).
   PubMed Web of Science ®Google Scholar
• Amer A, Fischer H, Li X. The natural history of pityriasis rosea in black American children: how correct is the “classic” description? Arch. Pediatr. Adolesc. Med.161, 503–506 (2007).
   PubMedGoogle Scholar
• Drago F, Broccolo F, Zaccharia et al. Pregnancy outcomes in pityriasis rosea. J. Am. Acad. Dermatol.58(5 Suppl. 1), S78–S83 (2008).
   PubMed Web of Science ®Google Scholar
• Bianca S, Ingegnosi C, Ciancio B, Gullotta G, Randazzo L, Ettore G. Pityriasis rosea in pregnancy. Reprod. Toxicol.24, 277–278 (2007).
   PubMedGoogle Scholar
• Chuh A, Lee A, Chan PK. Pityriasis rosea in pregnancy: specific diagnostic implications and management considerations. Aust. NZ J. Obstet. Gynaecol.45, 252–253 (2005).
   PubMedGoogle Scholar
• Spelman LJ, Robertson IM, Srtuttton GM, Weedon G. Pityriasis rosea-like eruption after bone marrow transplantation. J. Am. Acad. Dermatol.31, 348–351 (1994).
   PubMedGoogle Scholar
• Sadick NS, McNutt NS, Kaplan MH. Papulosquamous disorders dermatosis of AIDS. J. Am. Acad. Dermatol.22, 1270–1277 (1990).
   PubMed Web of Science ®Google Scholar
• Duvic M. Papulosquamous disorders associated with human immunodeficiency virus infection. Dermatol. Clin.9, 523–530 (1991).
   PubMedGoogle Scholar
• Raypara SM, Ormerod AD, Gallaway L. Adalimumab induced pityriasis rosea. J. Eur. Acad. Dermatol. Venereol.21, 1294–1296 (2007).
   PubMedGoogle Scholar
• Brazelli V, Pestinari F, Roveda E et al. Pityriasis rosea-like eruptions during treatment with imatinib mesylate: description of 3 cases. J. Am. Acad. Dermatol.53(Suppl.), S240–S243 (2005).
   Google Scholar
• Guaarneri C, Polimeni G, Nunnari G. Pityriasis rosea during etanercept therapy. Eur. Rev. Med. Pharmacol. Sci.13, 383–387 (2009).
   PubMedGoogle Scholar
• Atzori L, Pinna AL, Ferreli C, Aste N. Pityriasis rosea-like adverse reaction: review of the literature and experience of an Italian drug-surveillance center. Dermatol. Online J.12, 1 (2006).
   PubMedGoogle Scholar
• Zawar V. Pityriasis rose-like eruptions due to mustard oil application. Indian J. Dermatol. Venereol. Leprol.71, 282–284 (2005).
   PubMedGoogle Scholar
• Riess H. Pityriasis rosea following an injection of anti-diptheritic vaccine: report of a case. AMA Arch. Dermatol. Syph.43, 1008–1009 (1941).
   Google Scholar
• Witherspoon FG, Thibodaux DJ. Pityriasis rosea-like eruptions following smallpox vaccination. AMA Arch. Dermatol.76, 109–110 (1957).
   PubMedGoogle Scholar
• Sasmaz S. Karabiber H, Boran C, Garipardic M, Balat A. Pityriasis rosea-like eruptions due to pneumococcal vaccination in child with nephritic syndrome. J. Dermatol.30, 245–247 (2003).
   PubMedGoogle Scholar
• De Keyser F, Naeyaert JM, Hindryckx P et al. Immune-mediated pathology following hepatitis B vaccination: two cases of polyarteritis nodosa and one case of pityriasis rosea-like drug eruption. Clin. Exp. Rheuol.18, 81–85 (2000).
   PubMedGoogle Scholar
• Kaplan B, Grunwald MH, Halevy S. Pityriasis-rosea like eruptions associated with BCG vaccination (abstract). Isr. J. Med. Sci.25, 570–572 (1989).
   PubMedGoogle Scholar
• Watanabe T, Sugaya M, Nakamura K, Tamaki K. Human herpesvirus 7 and pityriasis rosea. J. Invest. Dermatol.113, 288–289 (1999).
   PubMedGoogle Scholar
• Watanabe T, Kawamura T, Jacob SE et al. Pityriasis rosea associated with systemic active infection with both herpes viruses 6& 7. J. Invest. Dermatol.119, 793–797 (2002).
   PubMed Web of Science ®Google Scholar
• Kosuge H, Tanaka-Taya K, Miyoshi H et al. Epidemiological study of human herpesvirus-6 and humanherpes-7 in pityriasis rosea. Br. J. Dermatol.143, 795–798 (2000).
   PubMed Web of Science ®Google Scholar
• Yasukawa M, Sada E, MacHino H, Fujita S. Reactivation of human herpesvirus 6 in pityriasis rosea. Br. J. Dermatol.140, 169–170 (1999).
   PubMedGoogle Scholar
• Kempf W, Adams V, Kleinhans M et al. Pityriasis rosea is not associated with human herpesvirus 7. Arch. Dermatol.135, 1070–1072 (1999).
   PubMed Web of Science ®Google Scholar
• Chuh A, Peiris JS. Lack of evidence of active humanherpes virus 7(HHV-7) in three cases of children with pityriasis rosea. Pediatr. Dermatol.18, 381–383 (2001).
   PubMedGoogle Scholar
• Chuh A, Chiu SS, Peiris JS. Human herpes virus 6 & 7 DNA in peripheral blood leucocytes and plasma in patients of pityriasis rosea by polymerase chain reaction: a prspective case control study. Acta Derm. Venereol.81, 289–290 (2001).
   PubMed Web of Science ®Google Scholar
• Karabulut AA, Kocac M, Yilmaz N, Eksioglu M. Detection of humanherpes virus 7 in pityriasis rosea by nested PCR. Int. J. Dermatol.41, 563–567 (2002).
   PubMed Web of Science ®Google Scholar
• Yildirim M, Aridogan BC, Baysal V, Inaloz HS. The role of human herpes virus 6 and 7 in the pathogenesis of pityriasis rosea. Int. J. Clin. Pract.58, 119–121 (2004).
   PubMed Web of Science ®Google Scholar
• Vág T, Sonkoly E, Kárpáti S, Kemény B, Ongrádi J. Avidity of antibodies to human herpesvirus 7 suggests primary infection in young adults with pityriasis rosea. J. Eur. Acad. Dermatol. Venereol.18, 738–740 (2004).
   PubMedGoogle Scholar
• Broccolo F, Drago F, Careddu AM et al. Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7. J. Invest. Dermatol.124, 1234–1240 (2005).
   PubMed Web of Science ®Google Scholar
• Chuh AA, Chan PK, Lee A. The detection of human herpesvirus-8 DNA in plasma and peripheral blood mononuclear cells in adult patients with pityriasis rosea by polymerase chain reaction. J. Eur. Acad. Dermatol. Venereol.20, 667–671 (2006).
   PubMedGoogle Scholar
• Prantsidis A, Rigopoulos D, Papatheodorou G et al. Detection of human herpesvirus 8 in the skin of patients with pityriasis rosea. Acta. Derm. Venereol.89, 604–606 (2009).
   PubMedGoogle Scholar
• Canpolat Kirac B, Adisen E, Bozdayi G et al. The role of human herpesvirus 6, human herpesvirus 7, Epstein–Barr virus and cytomegalovirus in the aetiology of pityriasis rosea. J. Eur. Acad. Dermatol. Venereol.23, 16–21 (2009).
   PubMed Web of Science ®Google Scholar
• Chuh AA, Kempf W. The identification of primary human herpesvirus 7 infection in young adults with pityriasis rosea by investigating avidity of antibodies. J. Eur Acad Dermatol Venereol.20, 629–630 (2006).
   PubMedGoogle Scholar
• Chuh AA, Chan HH, Zawar V. Is human herpesvirus 7 the causative agent of pityriasis rosea? A critical review. Int. J. Dermatol.43, 870–875 (2007).
   Google Scholar
• Gangemi S, Cannavò SP, Guarneri F et al. The CX3C-chemokine fractalkine (CX3CL1) is detectable in serum of patients affected by active pityriasis rosea. J. Eur. Acad. Dermatol. Venereol.20, 1366–1367 (2006).
   PubMed Web of Science ®Google Scholar
• Zawar V, Kumar R. Multiple recurrences of pityriasis rosea of Vidal: a novel presentation. Clin. Exp. Dermatol.34, e114–e116 (2009).
   PubMed Web of Science ®Google Scholar
• Drago F, Ranieri C, Brusati C, Lugani A, Rebora A. Pityriasis rosea, HHV7 and multiple sclerosis. A coincidence? Br. J. Dermatol.142, 1250 (2000).
   PubMedGoogle Scholar
• Garcia-F-Villalta MJ, Hernández-Nuñez A, Córdoba S, Fernández-Herrera J, García-Díez A. Atypical pityriasis rosea and Hodgkin’s disease. J. Eur. Acad. Dermatol. Venereol.18, 81–82 (2004).
   PubMed Web of Science ®Google Scholar
• Singhal A, Pandhi D, Rusia U. Purpuric pityriasis rosea-like eruptions: a cutaneous marker of acute myeloid leukemia. J. Eur. Acad. Dermatol. Venereol.21, 822–823 (2007).
   PubMedGoogle Scholar
• Chuh AA. Quality of life in children with pityriasis rosea: a prospective case control study. Pediatr. Dermatol.20, 474–478 (2003).
   PubMed Web of Science ®Google Scholar
• Chuh AA, Chan HH. Effect on quality of life in patients with pityriasis rosea: is it associated with rash severity? Int. J. Dermatol.44, 372–377 (2005).
   PubMed Web of Science ®Google Scholar
• Kaymak Y, Taner E. Anxiety and depression in patients with pityriasis rosea compared to patients with tinea versicolor. Dermatol. Nurs.20, 367–370 (2008).
   PubMedGoogle Scholar
• Valkova S, Trashlieva M, Christova P. UVB phototherapy for pityriasis rosea. J. Eur. Acad. Dermatol. Venereol.18, 111–112 (2004).
   PubMedGoogle Scholar
• Chuh A. Narrow band UVB phototherapy and oral acyclovir for pityriasis rosea. Photodermatol. Photoimmunol. Photomed.20(1), 64–65 (2004).
   PubMed Web of Science ®Google Scholar
• Castanedo-Cazares JP, Lepe V, Moncada B. Antivirals for pityriasis rosea. Photodermatol. Photoimmunol. Photomed.20, 110 (2004).
   PubMedGoogle Scholar
• Drago F, Vecchio F, Rebora A. Use of high-dose acyclovir in pityriasis rosea. J. Am. Acad. Dermatol.54, 82–85 (2006).
   PubMed Web of Science ®Google Scholar
• Sharma PK, Yadav TP, Gautam RK, Taneja N, Satyanarayan L. Erythromycin in pityriasis rosea: a double-blind, placebo controlled trial. J. Am. Acad. Dermatol.42, 241–244 (2000).
   PubMed Web of Science ®Google Scholar
• Rasi A, Tajziehchi L, Savabi-Nasab S. Oral erythromycin is ineffective in the treatment of pityriasis rosea. J. Drugs Dermatol.7, 35–38 (2008).
   PubMed Web of Science ®Google Scholar
• Bukhari IA. Oral erythromycin is ineffective in the treatment of pityriasis rosea. J. Drugs Dermatol.7, 625 (2008).
   PubMedGoogle Scholar
• Amer A, Fischer H. Azithromycin does not cure pityriasis rosea. Pediatrics117, 1702–1705 (2006).
   PubMed Web of Science ®Google Scholar
• Leonforte JF. Pityriasis rosea: exacerbation with corticosteroid treatment. Dermatologica163, 480–481 (1981).
   PubMedGoogle Scholar
• Chuh AA, Dofitas BL, Comisel GG et al. Interventions for pityriasis rosea. Cochrane Database Syst. Rev. (2), CD005068 (2007).
   Google Scholar